Table of Contents

Table of Contents

Preface

MicroRNAs in Breast Cancer
(Marc Lacroix, InTextoResearch, Baelen, Belgium)

Breast Cancer and Autophagy
(L.J. Armstrong, S.M. Gorski, The Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada and others)

The Evolving Role of Molecular Markers in the Diagnosis of Breast Cancer
(Danh Tran-Thanh, Susan J. Done, Department of Pathology, University Health Network, Toronto, Ontario, Canada and others)

Collagen Changes in the Extracellular Matrix of Tumor-Affected Human Breast: A Tale of OF/LB and Type V Collagens
(Claudio Luparello, Dipartimento di Biologia Cellulare e dello Sviluppo, Università, Viale delle Scienze, Palermo, Italy)

Breast Cancer Knowledge and Risk Factors Assessment at Primary Health Care Setting in Al Hassa, KSA.
(Tarek Tawfik Amin, Amira Gamal Abdul Rahman Community Medicine, Faculty of Medicine, Cairo University, Egypt and others)

Maspin and Cathepsin D Partnership in Regulating Mammary Gland Development and Breast Cancer
(Zhila Khalkhali-Ellis, Ming Zhang, Mary J.C. Hendrix, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois and others)

Subareolar Injection May Not Always Identify the Same Sentinel Lymph Nodes as Peritumoral Injection in Breast Cancer
(Masakuni Noguchi, Department of Breast Oncology, Kanazawa University Hospital, Kanazawa, Japan)

Immuno-Conjugates: New Prospects on Old Principles
(M.F. Barginear, D.R. Budman, The Tisch Cancer Insitute, The Mount Sinai School of Medicine, New York, NY, and others)

Relationship between Carbohydrate Expression Profiles of Cancer Cells and Prognosis of Breast Cancer Patients
(Takanori Kawaguchi, Masahiko Kanno, Shuji Asahi, Takashi Honda, Department of Pathology, Aizu Central Hospital, Aizu Wakamatsu, Japan, and others)

The HER2 Oncogene in Breast Cancer
(Myra F. Barginear, Daniel R. Budman, The Tisch Cancer Institute at the Mount Sinai School of Medicine, New York, NY, USA, and others)

Multi-Drug Resistance as a Problem Challenging Breast Cancer Chemotherapy
(Samar S. Azab, Ebtehal El-Demerdash, Ayman Al-Hendy, Pharmacology and Toxicology Department, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt, and other)

Signal Transduction and Metastasis Suppression: The Role of RAF Kinase Inhibitor Protein (RKIP) in Breast Cancer
(Zhi Yao, Rong Lu, Department of Immunology, Tianjin Medical University, Tianjin, China, and others)

BRCA1-Associated Proteins: Novel Targets for Breast Cancer Radiation Therapy
(Xiaowei Chen, Jamie L. Kistler, and Andrew K. Godwin, Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania)

Peripheral Benzodiazepine Receptor as a Biomarker for Breast Cancer
(Sutapa Mukhopadhyay, Salil K. Das, Department of Cancer Biology, Meharry Medical College, Nashville, Tennessee)

Phospholipids as Biomarkers for Breast Cancer
(Somdutta Sinha Roy, Salil K. Das, Department of Biochemistry and Cancer Biology, Meharry Medical College, Nashville, Tennessee)

Genetically Engineered T-Cells for Adoptive Immunotherapy of Breast Cancer
(Dinorah Friedmann-Morvinski, Victoria Marcu-Malina, Tova Waks, Zelig Eshhar, Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, California, USA, and others)

Trastuzumab Resistance
(E. Razis, G. Fountzilas, Asst. Div, 1st Oncology Department., “HYGEIA” Hospital, Marousi, Attiki, Greece, and others)

Lymphatic Spreading Propensity and Aberrant MUC1 Bearing TN/TN-Like Carbohydrate of Aggressive Breast Cancer Cells
(Takanori Kawaguchi, Masahiko Kanno, Hiroshi Takazawa, Shunsuke Imai, Jyunji Morimoto, Satomi Haga, Takashi Honda, Department of Pathology, Aizu Central Hospital, Aizu Wakamatsu, Japan, and others)

Micro- and Nano-Particulate Drug Delivery Systems for Cancer Treatment
(Jose L. Arias – Dept. of Pharmacy and Pharmaceutical Technology, Univ. of Granada, Granada, Spain)

Geldanamycin Derivatives as Promising Anticancer Drugs: Therapy via Hsp90 Inhibition
(Alexander E. Kabakov – Dept. of Radiation Biochemistry, Medical Radiology Research Center, Obninsk, Russia)

Synergistic Antitumor Activity of Metronomic Dosing Chemotherapy in Combination with Liposomal Anticancer Drug
(Tatsuhiro Ishida, Hiroshi Kiwada – Dept. of Pharmacokinetics and Biopharmaceutics, Univ. of Tokushima, Sho-machi, Tokushima, Japan)p

Organotin Polyethers as Anticancer Drugs
(Charles E. Carraher, Jr., Michael R. Roner, Girish Barot – Florida Atlantic Univ., Dept. of Chemistry and Biochemistry, Boca Raton, FL and others)

Studies on Anticancer Agents: Phenolic Compounds and their Pharmacological Activity
(Maria Dolors Pujol, Isabel Sanchez – Laboratori de Quimica Farmaceutica, Univ. de Barcelona, Barcelona, Spain)

Design of Novel Anticancer Drugs Utilizing Busulfan for Optimizing Pharmacological Properties and Pattern Recognition Techniques for Elucidation of Clinical Efficacy
(Ronald Bartzatt – Univ. of Nebraska, Chemistry Department, Omaha, NE, USA)

Analysis of Associations Among Novel Property Descriptors and their Capacity in Determining Clinical Efficacy by Utilizing Pattern Recognition Technigues
(Ronald Bartzatt – Univ. of Nebraska, Chemistry Department, Omaha, NE, USA)

Insights into the Mode of Action of Investigational Ruthenium(III) Cytotoxins from Electrochemical and Biological Studies
(Erwin Reisner – Univ. of Oxford, Inorganic Chemistry Laboratory, Oxford, UK)

Marina Crystal Minerals(MCM) Induce Apoptosis of Human Metastatic Breast Cancer MDA-MB-231 Cells In Vitro
(Mamdooh Ghoneum, Takeshi Ogura, Sastry Gollapudi- Dept. of Otolaryngology, Drew Univ. of Medicine and Science, Los Angeles, CA, USA and others)

Index